KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to -$4.0 million.

  • Emergent BioSolutions' Change in Account Payables rose 8260.87% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.0 million, marking a year-over-year decrease of 33.44%. This contributed to the annual value of -$33.0 million for FY2024, which is 41132.08% down from last year.
  • Emergent BioSolutions' Change in Account Payables amounted to -$4.0 million in Q3 2025, which was up 8260.87% from -$10.4 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Change in Account Payables registered a high of $31.0 million during Q1 2023, and its lowest value of -$23.0 million during Q3 2024.
  • Over the past 5 years, Emergent BioSolutions' median Change in Account Payables value was -$4.5 million (recorded in 2021), while the average stood at -$3.0 million.
  • Per our database at Business Quant, Emergent BioSolutions' Change in Account Payables tumbled by 120000.0% in 2021 and then skyrocketed by 31088.44% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Change in Account Payables (Quarter) stood at -$5.1 million in 2021, then surged by 56.86% to -$2.2 million in 2022, then plummeted by 222.73% to -$7.1 million in 2023, then tumbled by 43.66% to -$10.2 million in 2024, then surged by 60.78% to -$4.0 million in 2025.
  • Its Change in Account Payables was -$4.0 million in Q3 2025, compared to -$10.4 million in Q2 2025 and -$5.4 million in Q1 2025.